​

Nyxoah (NYXH) Stock Forecast, Price Target & Predictions

OverviewChartTranscripts

NYXH Stock Forecast

Nyxoah (NYXH) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $19.00, with a high of $27.00 and a low of $15.00. This represents a 151.32% increase from the last price of $7.56.

- $6 $12 $18 $24 $30 High: $27 Avg: $19 Low: $15 Last Closed Price: $7.56

NYXH Stock Rating

Nyxoah stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

NYXH Price Target Upside V Benchmarks

TypeNameUpside
StockNyxoah151.32%
SectorHealthcare Stocks 23.68%
IndustryMedical Instruments & Supplies Stocks25.40%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$17.00
Last Closing Price$7.56$7.56$7.56
Upside/Downside--124.87%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25131--5
May, 25231--6
Apr, 25231--6
Mar, 25231--6
Feb, 25231--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 14, 2024Edward WhiteH.C. Wainwright$17.00$9.6077.08%124.87%
May 24, 2024Edward WhiteH.C. Wainwright$18.00$8.33116.09%138.10%
May 15, 2024Ross OsbornCantor Fitzgerald$17.00$9.5877.45%124.87%
May 15, 2024Suraj KaliaOppenheimer$15.00$9.5856.58%98.41%
Mar 20, 2024Jonathan BlockStifel Nicolaus$27.00$13.9094.24%257.14%
Mar 14, 2024Suraj KaliaOppenheimer$20.00$16.5820.63%164.55%
May 06, 2022Suraj KaliaOppenheimer$30.00$14.72103.80%296.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 14, 2024H.C. WainwrightBuyBuyhold
Jul 02, 2024H.C. WainwrightBuyBuyhold
May 24, 2024H.C. WainwrightBuyBuyhold
May 15, 2024Cantor FitzgeraldOverweightOverweighthold
May 15, 2024OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.68$-1.16$-1.21------
Avg Forecast$-0.76$-1.04$-1.04$-1.54$-1.74$-1.78$-1.36$-0.68$0.10
High Forecast$-0.50$-0.69$-0.68$-1.42$-1.63$-1.32$-1.25$-0.44$0.14
Low Forecast$-0.97$-1.33$-1.47$-1.68$-1.83$-2.29$-1.47$-0.93$0.07
Surprise %-10.53%11.54%16.35%------

Revenue Forecast

$0 $80M $160M $240M $320M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$69.00K$852.00K$3.08M$4.30M-----
Avg Forecast$499.38K$2.19M$4.48M$4.25M$5.78M$28.95M$75.82M$185.50M$294.62M
High Forecast$607.36K$2.67M$5.89M$4.48M$6.07M$37.37M$77.77M$237.91M$377.85M
Low Forecast$370.25K$1.63M$3.30M$4.15M$5.35M$21.66M$73.86M$134.56M$213.72M
Surprise %-86.18%-61.13%-31.24%1.14%-----

Net Income Forecast

$-65M $-51M $-37M $-23M $-9M $5M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-12.24M$-27.62M$-31.23M------
Avg Forecast$-21.27M$-29.12M$-29.21M$-43.21M$-48.36M$-62.72M$-38.05M$-19.04M$2.83M
High Forecast$-14.12M$-19.33M$-19.15M$-39.63M$-45.68M$-36.87M$-34.88M$-12.18M$3.87M
Low Forecast$-27.25M$-37.30M$-41.12M$-46.94M$-51.04M$-63.95M$-41.22M$-25.90M$1.82M
Surprise %-42.44%-5.15%6.90%------

NYXH Forecast FAQ

Is Nyxoah stock a buy?

Nyxoah stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Nyxoah is a favorable investment for most analysts.

What is Nyxoah's price target?

Nyxoah's price target, set by 5 Wall Street analysts, averages $19 over the next 12 months. The price target range spans from $15 at the low end to $27 at the high end, suggesting a potential 151.32% change from the previous closing price of $7.56.

How does Nyxoah stock forecast compare to its benchmarks?

Nyxoah's stock forecast shows a 151.32% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the medical instruments & supplies stocks industry (25.40%).

What is the breakdown of analyst ratings for Nyxoah over the past three months?

  • June 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 33.33% Strong Buy, 50.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 50.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is Nyxoah’s EPS forecast?

Nyxoah's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.74, marking a 0% decrease from the reported $0 in 2023. Estimates for the following years are $-1.78 in 2025, $-1.36 in 2026, $-0.68 in 2027, and $0.1 in 2028.

What is Nyxoah’s revenue forecast?

Nyxoah's average annual revenue forecast for its fiscal year ending in December 2024 is $5.78M, reflecting a 34.39% increase from the reported $4.3M in 2023. The forecast for 2025 is $28.95M, followed by $75.82M for 2026, $185.5M for 2027, and $294.62M for 2028.

What is Nyxoah’s net income forecast?

Nyxoah's net income forecast for the fiscal year ending in December 2024 stands at $-48.364M, representing a 0% decrease from the reported $0 in 2023. Projections indicate $-62.72M in 2025, $-38.049M in 2026, $-19.04M in 2027, and $2.83M in 2028.